Alexander A. Fitzpatrick is Secretary at Evofem Biosciences, Inc. (EVFM). They have made 7 open-market trades across 3 companies since 2011, most recently 2026-06-12.
CIK 0001398595
6 open-market purchases totalling $560K since 2011, against 1 sale. Across 5 scored buys the stock is up 28.2% at ninety days, and 24.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 60% |
| Avg Move | +12.3% | +11.3% | +28.2% |
| Alpha | +10.4% | +9.8% | +24.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SPRY | SELL · 10b5-1 | 2026-06-12 | 2026-06-12 | $10.00 | $34K | -18.7% | -21.4% | -48.7% |
| SPRY | SELL | 2025-05-20 | 2025-05-22 | $14.10 | $2.9M | -4.8% | +14.1% | +0.6% |
| SPRY | BUY | 2023-09-28 | 2023-10-02 | $3.73 | $495K | -6.7% | -11.4% | +38.8% |
| EVFM | BUY | 2021-12-20 | 2021-12-20 | $0.39 | $10K | -9.0% | +18.2% | -5.4% |
| EVFM | BUY | 2021-06-10 | 2021-06-10 | $1.03 | $10K | +1.8% | -14.6% | -26.6% |
| EVFM | BUY | 2020-11-17 | 2020-11-18 | $2.20 | $20K | -6.5% | -9.1% | +72.8% |
| EVFM | BUY | 2018-08-20 | 2018-08-21 | $2.21 | $11K | +82.1% | +73.5% | +61.4% |
| VRNM | BUY | 2011-08-18 | 2011-08-22 | $1.90 | $14K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.